Milestone Pharmaceuticals IncNASDAQ:MIST
- LAST PRICE1.6900
- TODAY'S CHANGE (%)0.0500 (3.0488%)
- Bid / Lots1.6300/ 6
- Ask / Lots1.6900/ 10
- Open / Previous Close1.6800 / 1.6400
- Day Range
- 52 Week Range
- Volume85,566
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | MIST |
|---|---|---|
| 09:32 ET | 1025 | 1.68 |
| 09:36 ET | 1900 | 1.68 |
| 09:38 ET | 2398 | 1.6693 |
| 09:59 ET | 3000 | 1.64 |
| 10:15 ET | 100 | 1.64 |
| 10:24 ET | 100 | 1.6464 |
| 10:28 ET | 300 | 1.63 |
| 10:32 ET | 2000 | 1.6464 |
| 10:33 ET | 500 | 1.645 |
| 10:39 ET | 1000 | 1.6494 |
| 10:42 ET | 4301 | 1.65 |
| 10:44 ET | 1142 | 1.65 |
| 11:04 ET | 300 | 1.6493 |
| 11:11 ET | 146 | 1.6498 |
| 11:24 ET | 620 | 1.645 |
| 11:33 ET | 200 | 1.65 |
| 11:40 ET | 2000 | 1.6499 |
| 11:49 ET | 1895 | 1.65 |
| 11:58 ET | 2000 | 1.645 |
| 12:00 ET | 1505 | 1.65 |
| 12:02 ET | 200 | 1.65 |
| 12:03 ET | 4940 | 1.67 |
| 12:12 ET | 1252 | 1.65 |
| 12:39 ET | 300 | 1.6519 |
| 12:41 ET | 1900 | 1.65 |
| 12:43 ET | 200 | 1.6566 |
| 01:01 ET | 100 | 1.66 |
| 01:35 ET | 1916 | 1.65 |
| 01:39 ET | 100 | 1.66 |
| 01:57 ET | 200 | 1.65 |
| 02:00 ET | 800 | 1.66 |
| 02:11 ET | 9690 | 1.65 |
| 02:22 ET | 2000 | 1.6521 |
| 02:27 ET | 473 | 1.65 |
| 02:40 ET | 255 | 1.6401 |
| 02:47 ET | 300 | 1.66 |
| 02:49 ET | 130 | 1.65 |
| 03:05 ET | 100 | 1.66 |
| 03:07 ET | 11735 | 1.68 |
| 03:23 ET | 4935 | 1.66 |
| 03:38 ET | 2756 | 1.6699 |
| 03:45 ET | 113 | 1.67 |
| 03:54 ET | 1929 | 1.66 |
| 03:56 ET | 4750 | 1.6699 |
| 03:57 ET | 100 | 1.67 |
| 03:59 ET | 2314 | 1.69 |
May 2, 2024
Apr 17, 2024
Milestone(R) Pharmaceuticals to Present Data on Etripamil at the Preventative Cardiovascular Nursing Symposium, from 8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
8:00AM ET on Wednesday Apr 17, 2024 by Dow Jones
Apr 8, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Milestone Pharmaceuticals Inc | 89.8M | -1.2x | --- |
Barinthus Biotherapeutics PLC | 84.8M | -1.1x | --- |
BioXcel Therapeutics Inc | 85.9M | -0.4x | --- |
Beyondspring Inc | 87.6M | -4.2x | --- |
Oramed Pharmaceuticals Inc | 95.2M | 18.5x | --- |
CEL-SCI Corp | 88.0M | -2.4x | --- |
Company Information
Milestone Pharmaceuticals Inc. is a Canada-based biopharmaceutical company. The Company is focused on the development and commercialization of cardiovascular medicines. Its lead product candidate, etripamil, is a potent rapid-onset calcium channel blocker that the Company designed and is developing as a rapid-onset nasal spray to be administered by patients. The Company is also focused on developing etripamil to treat paroxysmal supraventricular tachycardia (PSVT) with a subsequent indication to treat atrial fibrillation with rapid ventricular rate (AFib-RVR) and other cardiovascular indications.
Contact Information
- Headquarters
- 420-1111 boul. Dr.-Frederik-PhilipsMONTREAL, QC, Canada H4M 2X6
- Phone
- 514-336-0444
- Fax
- 514-336-0444
Executives
- Non-Executive Independent Chairman of the Board
- Robert Wills
- President, Chief Executive Officer, Director
- Joseph Oliveto
- Chief Financial Officer, Executive Vice President of Corporate Development
- Amit Hasija
- Chief Operating Officer
- Jeffrey Nelson
- Chief Medical Officer
- David Bharucha
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $89.8M |
|---|---|
Revenue (TTM) | $1.0M |
Shares Outstanding | 53.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.77 |
EPS | $-1.39 |
Book Value | $0.50 |
P/E Ratio | -1.2x |
Price/Sales (TTM) | 89.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -6,109.80% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
